P2RX7


Summary: The product of this gene belongs to the family of purinoceptors for ATP. This receptor functions as a ligand-gated ion channel and is responsible for ATP-dependent lysis of macrophages through the formation of membrane pores permeable to large molecules. Activation of this nuclear receptor by ATP in the cytoplasm may be a mechanism by which cellular activity can be coupled to changes in gene expression. Multiple alternatively spliced variants have been identified, most of which fit nonsense-mediated decay (NMD) criteria. [provided by RefSeq, Jul 2010].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location
OMIM IDMIM:602566
PHARMGKB IDPA32866
Map Location12q24.31

GO terms in P2RX7


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
MF ISS GO:0001530 lipopolysaccharide binding
MF IBA GO:0001614 purinergic nucleotide receptor activity
MF IDA GO:0001614 purinergic nucleotide receptor activity
MF IBA GO:0004931 extracellularly ATP-gated cation channel activity
MF IDA GO:0004931 extracellularly ATP-gated cation channel activity
MF TAS GO:0004931 extracellularly ATP-gated cation channel activity
Showing 1 to 6 of 97 rows rows per page

Gene expression in normal tissue: P2RX7

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

Pathways in P2RX7


Loading, please wait...
Database
Pathway ID
Pathway Des.
reactome R-HSA-109582 Hemostasis
reactome R-HSA-139853 Elevation of cytosolic Ca2+ levels
reactome R-HSA-168249 Innate Immune System
reactome R-HSA-168249 Innate Immune System
reactome R-HSA-168256 Immune System
reactome R-HSA-168256 Immune System
Showing 1 to 6 of 17 rows rows per page

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD171 Pemetrexed 2
iGMDRD226 ML006 2
iGMDRD187 BRD9876 2
iGMDRD260 FQI-2 1
Showing 1 to 4 of 64 rows rows per page

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in P2RX7

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​